Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 10826
TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571728(US11447477, Compound 150 | US11447477, Compound 4)
Affinity DataIC50: 55nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571731(BDBM50551166 | Synthetic Route of N-(3-bromo-4-flu...)
Affinity DataIC50: 59nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571757(US11447477, Compound 92)
Affinity DataIC50: 64nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571745(US11447477, Compound 24)
Affinity DataIC50: 69nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571751(US11447477, Compound 78)
Affinity DataIC50: 69nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571742(US11447477, Compound 20)
Affinity DataIC50: 79nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571728(US11447477, Compound 150 | US11447477, Compound 4)
Affinity DataIC50: 81nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571733(US11447477, Compound 9)
Affinity DataIC50: 84nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571730(US11447477, Compound 6)
Affinity DataIC50: 88nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571746(US11447477, Compound 25)
Affinity DataIC50: 96nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571759(US11447477, Compound 151)
Affinity DataIC50: 101nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571749(US11447477, Compound 28)
Affinity DataIC50: 107nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571732(US11447477, Compound 8)
Affinity DataIC50: 112nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571740(US11447477, Compound 18)
Affinity DataIC50: 114nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571753(US11447477, Compound 85)
Affinity DataIC50: 115nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571741(US11447477, Compound 19)
Affinity DataIC50: 119nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571756(US11447477, Compound 91)
Affinity DataIC50: 128nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571736(US11447477, Compound 12)
Affinity DataIC50: 133nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571743(US11447477, Compound 21)
Affinity DataIC50: 141nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571752(US11447477, Compound 81)
Affinity DataIC50: 142nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571739(US11447477, Compound 16)
Affinity DataIC50: 151nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571754(US11447477, Compound 86)
Affinity DataIC50: 167nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571750(US11447477, Compound 29)
Affinity DataIC50: 173nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571726(US11447477, Compound 2)
Affinity DataIC50: 182nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571755(US11447477, Compound 89)
Affinity DataIC50: 183nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571744(US11447477, Compound 23)
Affinity DataIC50: 183nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571735(US11447477, Compound 11)
Affinity DataIC50: 206nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571737(US11447477, Compound 13)
Affinity DataIC50: 214nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571734(US11447477, Compound 10)
Affinity DataIC50: 254nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571729(US11447477, Compound 5)
Affinity DataIC50: 276nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571738(US11447477, Compound 14)
Affinity DataIC50: 279nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571747(US11447477, Compound 26)
Affinity DataIC50: 340nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571727(US11447477, Compound 3)
Affinity DataIC50: 430nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Hinova Pharmaceuticals

US Patent
LigandPNGBDBM571748(US11447477, Compound 27)
Affinity DataIC50: 628nMAssay Description:The tested compounds and the reference compounds are dissolved in DMSO to prepare a high concentration of storage solution. The stock solution of ref...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/19/2022
Entry Details
US Patent